To ensure a comprehensive approach to HCV elimination, MoLHSA developed a Strategic Plan for Elimination of Hepatitis C in Georgia (7).
MoLHSA is working with CDC and other international partners to address challenges and introduce innovative strategies.
Together with CDC, the World Health Organization (WHO), and other international partners, Georgia's MoLHSA developed a technical advisory group (TAG), which convened its first meeting in November 2015.
Georgia's MoLHSA is anticipating this growth and is working with partners to ensure the system is upgraded to handle additional demands.
The exception is of course mandatory HIV testing of seamen, which is the only "preventive measure" taken from a central level and comes from the MoLHSA
. This is worth noting, because it demonstrates that someone somewhere at a central level must have perceived the threat of transmitting HIV via the maritime sector as real.
CDC, MoLHSA, and other national and international partners met in 2014 and identified a national HCV seroprevalence survey and improved access to new curative HCV treatment as initial priorities.
A data management system (STOP-C) was developed to collect demographic, diagnostic, clinical, and pharmacy data on patients registered for treatment, which permits data entry by health care providers as well as the Central Social Service Agency (based at MoLHSA in Tbilisi).
MoLHSA initially limited the number of participating sites, to ensure quality and appropriate clinical decision making; the recent addition of three new sites should reduce program delays and facilitate program expansion, and assessment of additional providers and laboratories is ongoing.